Healthpeak Properties
DOC (NYSE)
Healthpeak Properties (DOC) stands out as a strong performer among monthly payers, offering high expected returns and reliable REIT dividends. Currently, the stock has a dividend yield of 6.31%, though it has experienced a 1-year return of -16.46% and a 5-year return of -39.29%. Analysts maintain a median 12-month price target of $20.00, reflecting a consensus "Hold" rating, which suggests a cautious outlook amid recent concerns about the lab market and biotech funding.
Pros:
- Strong expected returns
- Reliable REIT dividends
Cons:
- Negative 1-year and 5-year returns
- Market volatility risk
Healthpeak Properties (DOC) may be suitable for income-focused investors seeking exposure to the healthcare real estate sector, particularly those comfortable with the potential volatility indicated by its recent negative returns. However, given the cautious outlook reflected in analysts' ratings, investors should weigh the risks associated with its performance against the appeal of its attractive dividend yield.